1. Home
  2. EDAP vs MCHX Comparison

EDAP vs MCHX Comparison

Compare EDAP & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDAP
  • MCHX
  • Stock Information
  • Founded
  • EDAP 1979
  • MCHX 2003
  • Country
  • EDAP France
  • MCHX United States
  • Employees
  • EDAP N/A
  • MCHX N/A
  • Industry
  • EDAP Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MCHX Business Services
  • Sector
  • EDAP Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • EDAP Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • EDAP 94.2M
  • MCHX 79.9M
  • IPO Year
  • EDAP 1997
  • MCHX 2004
  • Fundamental
  • Price
  • EDAP $2.45
  • MCHX $1.70
  • Analyst Decision
  • EDAP Strong Buy
  • MCHX
  • Analyst Count
  • EDAP 2
  • MCHX 0
  • Target Price
  • EDAP $14.00
  • MCHX N/A
  • AVG Volume (30 Days)
  • EDAP 207.4K
  • MCHX 33.5K
  • Earning Date
  • EDAP 11-07-2024
  • MCHX 10-31-2024
  • Dividend Yield
  • EDAP N/A
  • MCHX N/A
  • EPS Growth
  • EDAP N/A
  • MCHX N/A
  • EPS
  • EDAP N/A
  • MCHX N/A
  • Revenue
  • EDAP $70,722,730.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • EDAP $8.00
  • MCHX N/A
  • Revenue Next Year
  • EDAP $14.58
  • MCHX $4.20
  • P/E Ratio
  • EDAP N/A
  • MCHX N/A
  • Revenue Growth
  • EDAP 12.17
  • MCHX N/A
  • 52 Week Low
  • EDAP $2.27
  • MCHX $1.11
  • 52 Week High
  • EDAP $8.50
  • MCHX $2.15
  • Technical
  • Relative Strength Index (RSI)
  • EDAP 38.04
  • MCHX 45.01
  • Support Level
  • EDAP $2.42
  • MCHX $1.67
  • Resistance Level
  • EDAP $2.72
  • MCHX $1.90
  • Average True Range (ATR)
  • EDAP 0.17
  • MCHX 0.13
  • MACD
  • EDAP -0.02
  • MCHX -0.00
  • Stochastic Oscillator
  • EDAP 6.23
  • MCHX 33.33

About EDAP EDAP TMS S.A.

Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its global activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: